Solstein Capital’s Gilead Sciences GILD Stock Holding History

Solstein Capital’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$131K	Hold	1,036	–	–	0.04%	161
2026 Q1	$144K	Hold	1,036	–	–	0.06%	146
2025 Q4	$127K	Hold	1,036	–	–	0.05%	149
2025 Q3	$115K	Hold	1,036	–	–	0.03%	150
2025 Q2	$115K	Hold	1,036	–	–	0.06%	144
2025 Q1	$116K	Hold	1,036	–	–	0.07%	123
2024 Q4	$95.7K	Hold	1,036	–	–	0.05%	131
2024 Q3	$86.9K	Hold	1,036	–	–	0.05%	137
2024 Q2	$71.1K	Hold	1,036	–	–	0.05%	135
2024 Q1	$75.9K	Hold	1,036	–	–	0.05%	125
2023 Q4	$83.9K	Hold	1,036	–	–	0.06%	126
2023 Q3	$77.6K	Hold	1,036	–	–	0.07%	128
2023 Q2	$79.8K	Hold	1,036	–	–	0.07%	129
2023 Q1	$86K	Hold	1,036	–	–	0.07%	123
2022 Q4	$88.9K	Hold	1,036	–	–	0.07%	134
2022 Q3	$64K	Hold	1,036	–	–	0.06%	142
2022 Q2	$64K	Hold	1,036	–	–	0.05%	162
2022 Q1	$62K	Hold	1,036	–	–	0.04%	178
2021 Q4	$75K	Hold	1,036	–	–	0.05%	183
2021 Q3	$72K	Hold	1,036	–	–	0.04%	204
2021 Q2	$71K	Hold	1,036	–	–	0.09%	194
2021 Q1	$67K	Buy	+1,036	New	+$66.8K	0.09%	189
2020 Q4	–	Sell	-1,036	Closed	-$65K	–	136
2020 Q3	$65K	Hold	1,036	–	–	0.15%	117
2020 Q2	$80K	Hold	1,036	–	–	0.19%	90
2020 Q1	$77K	Buy	1,036 +480	+86%	+$33.2K	0.3%	57
2019 Q4	$36K	Buy	+556	New	+$36.2K	0.07%	128

Other funds holding GILD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Solstein Capital's GILD Position: Q2 2026 in Review

Solstein Capital held its Gilead Sciences (GILD) position steady in Q2 2026 at 1,036 shares worth $131K. The position accounts for 0.04% of the portfolio, ranked #161.

Solstein Capital first reported a position in GILD in Q4 2019 and has held it in 26 quarters since. The position peaked at $144K in Q1 2026. 2,281 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

Solstein Capital held 1,036 shares of Gilead Sciences worth $131K as of Q2 2026.
Solstein Capital left its Gilead Sciences share count unchanged in Q2 2026.
Gilead Sciences made up 0.04% of Solstein Capital's portfolio in Q2 2026, its #161 holding.
Solstein Capital first reported a position in Gilead Sciences in Q4 2019 and has held it in 26 quarters since.
Solstein Capital's Gilead Sciences position peaked at $144K in Q1 2026.
2,281 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Solstein Capital's 13F filing for Q2 2026, filed 13 Aug 2026.